ClinicalTrials.gov
ClinicalTrials.gov Menu

Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization (CUP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00291811
Expanded Access Status : Approved for marketing
First Posted : February 15, 2006
Last Update Posted : February 11, 2014
Sponsor:
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company )

No Study Results Posted on ClinicalTrials.gov for this Study
  Expanded Access Status : Approved for marketing
  Primary Completion Date : No date given
  Study Completion Date : No date given